Breach of IL-12 monopoly in the initiation of type 1 immunity to intracellular infections: IL-12 is not required for host defense against viral infections

被引:0
作者
Xing, Z
机构
[1] McMaster Univ, Hlth Sci Ctr, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Hlth Sci Ctr, Div Infect Dis, Ctr Gene Therapeut, Hamilton, ON L8N 3Z5, Canada
关键词
type; 1; immunity; intracellular infection; cytokine; interleukin-12; myobacterial infection; viral infection;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
IL-12 is believed to play an important role in type 1 T-cell differentiation and type 1 cytokine IFN-gamma release by T and TK-cells and macrophages in host defense against intracellular infections by bacteria, parasites, fungi and viruses. However, recent studies by us and others have provided unequivocal evidence that while IL-12 is critically required for the development of type 1 immunity to the majority of intracellular bacterial, parasitic and fungal infections, it is not required for anti-viral type 1 immune responses. These findings have provoked our re-thinking about the role of IL-12 in type 1 immunity and the search for additional cytokines capable of initiating anti-viral type 1 immunity. We hypothesize that there exist multiple cytokines including IL-12 which play a redundant role in the initiation of type 1 immunity against viral infection. These cytokines are likely released from not only antigen-presenting macrophages/dendritic cells but many other cell types which suits the mode of viral infection. The existence of multiple factors capable of driving type 1 immunity endows the host with additional safeguards to cope with prevalent viral foes.
引用
收藏
页码:689 / 694
页数:6
相关论文
共 31 条
[1]   Mendelian susceptibility to mycobacterial infection in man [J].
Altare, F ;
Jouanguy, E ;
Lamhamedi, S ;
Döffinger, R ;
Fischer, A ;
Casanova, JL .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (04) :413-417
[2]   The neglected role of type I interferon in the T-cell response: Implications for its clinical use [J].
Belardelli, F ;
Gresser, I .
IMMUNOLOGY TODAY, 1996, 17 (08) :369-372
[3]   IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenes [J].
Brombacher, F ;
Dorfmüller, A ;
Magram, J ;
Dai, WJ ;
Köhler, G ;
Wunderlin, A ;
Palmer-Lehmann, K ;
Gately, MK ;
Alber, G .
INTERNATIONAL IMMUNOLOGY, 1999, 11 (03) :325-332
[4]   Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis [J].
Cooper, AM ;
Magram, J ;
Ferrante, J ;
Orme, IM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :39-45
[5]   Two roads diverged:: Interferon α/β- and interleukin 12-mediated pathways in promoting T cell interferon γ responses during viral infection [J].
Cousens, LP ;
Peterson, R ;
Hsu, S ;
Dorner, A ;
Altman, JD ;
Ahmed, R ;
Biron, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (08) :1315-1327
[6]   Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection [J].
Cousens, LP ;
Orange, JS ;
Su, HC ;
Biron, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (02) :634-639
[7]   INTERLEUKIN-12 GENE-EXPRESSION AFTER VIRAL-INFECTION IN THE MOUSE [J].
COUTELIER, JP ;
VANBROECK, J ;
WOLF, SF .
JOURNAL OF VIROLOGY, 1995, 69 (03) :1955-1958
[8]  
De Maeyer Edward, 1998, P491
[9]  
Ely KH, 1999, J IMMUNOL, V162, P5449
[10]   An alternate pathway for type 1 T cell differentiation [J].
Feng, CG ;
Watanabe, S ;
Maruyama, S ;
Suzuki, G ;
Sato, M ;
Furuta, T ;
Kojima, S ;
Taki, S ;
Asano, Y .
INTERNATIONAL IMMUNOLOGY, 1999, 11 (08) :1185-1194